These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38978299)

  • 1. Effects of co-administration of lamotrigine on valproate transfer across the placenta and its brain entry in developing Genetic Absence Epilepsy Rats from Strasbourg (GAERS).
    Qiu F; Huang Y; Dziegielewska KM; Habgood MD; Saunders NR
    Eur J Neurosci; 2024 Aug; 60(4):4536-4551. PubMed ID: 38978299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entry of antiepileptic drugs (valproate and lamotrigine) into the developing rat brain.
    Toll SJ; Qiu F; Huang Y; Habgood MD; Dziegielewska KM; Nie S; Saunders NR
    F1000Res; 2021; 10():384. PubMed ID: 34249340
    [No Abstract]   [Full Text] [Related]  

  • 3. Entry of the antipsychotic drug, olanzapine, into the developing rat brain in mono- and combination therapies.
    Huang Y; Qiu F; Habgood M; Nie S; Dziegielewska K; Saunders N
    F1000Res; 2022; 11():1417. PubMed ID: 36798113
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of in utero exposure to valproate or levetiracetam on the seizures and newborn histopathology of genetic absence epilepsy rats.
    Can Kantarci B; Sanli A; Gavas S; Toplu A; Nur Turgan Asik Z; Tugce Cilingir-Kaya O; Gulcebi Idrizoglu M; Ercan F; Onat F
    Neurosci Lett; 2022 Apr; 776():136574. PubMed ID: 35271996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsy.
    Elms J; Powell KL; van Raay L; Dedeurwaerdere S; O'Brien TJ; Morris MJ
    PLoS One; 2013; 8(9):e73505. PubMed ID: 24039965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of lamotrigine with sodium valproate.
    Panayiotopoulos CP; Ferrie CD; Knott C; Robinson RO
    Lancet; 1993 Feb; 341(8842):445. PubMed ID: 8094217
    [No Abstract]   [Full Text] [Related]  

  • 9. Maternal valproate dosage and foetal malformations.
    Vajda FJ; Eadie MJ
    Acta Neurol Scand; 2005 Sep; 112(3):137-43. PubMed ID: 16097954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD003032. PubMed ID: 33475151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy.
    Cohen JM; Alvestad S; Suarez EA; Schaffer A; Selmer RM; Havard A; Bateman BT; Cesta CE; Zoega H; Odsbu I; Huybrechts KF; Kjerpeseth LJ; Straub L; Leinonen MK; Bjørk MH; Nørgaard M; Gissler M; Ulrichsen SP; Hernandez-Diaz S; Tomson T; Furu K
    Neurology; 2024 Jan; 102(2):e207996. PubMed ID: 38165339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.
    Campbell E; Kennedy F; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ; Craig J; Morrow J
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1029-34. PubMed ID: 24444855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine.
    Deshmukh U; Adams J; Macklin EA; Dhillon R; McCarthy KD; Dworetzky B; Klein A; Holmes LB
    Neurotoxicol Teratol; 2016; 54():5-14. PubMed ID: 26791321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Adamson PC;
    Epilepsia; 2013 Jan; 54(1):141-55. PubMed ID: 23167925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy.
    Dedeurwaerdere S; van Raay L; Morris MJ; Reed RC; Hogan RE; O'Brien TJ
    Seizure; 2011 Jan; 20(1):72-9. PubMed ID: 21093310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives.
    Tomson T; Luef G; Sabers A; Pittschieler S; Ohman I
    Neurology; 2006 Oct; 67(7):1297-9. PubMed ID: 17030773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003032. PubMed ID: 16235312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2003; (3):CD003032. PubMed ID: 12917940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.